Concepedia

Camille Daugrois

CD

Statistics

Publications

5

Citations

124

H-Index

5

Active since

2013

Affiliations

Inserm(Current)

Université Toulouse III - Paul Sabatier

Centre de Recherches en Cancérologie de Toulouse

Centre National de la Recherche Scientifique

Lymphoma Study Association

Camille Daugrois is an author at Inserm specializing in oncology, molecular oncology, and microrna regulation in cancer.

Publications per year

2013–2021

5

Publications

5

Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth

Coralie Hoareau‐Aveilla, Thibaud Valentin, Camille Daugrois et al. · Journal of Clinical Investigation · 2015 · 38 citations · Full text

, , +17

Recombinant Human IL-15 <i>Trans</i>-Presentation by B Leukemic Cells from Chronic Lymphocytic Leukemia Induces Autologous NK Cell Proliferation Leading to Improved Anti-CD20 Immunotherapy

Emilie Laprévotte, Grégory Voisin, Loïc Ysebaert et al. · The Journal of Immunology · 2013 · 29 citations

, , +14

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells

Annabelle Congras, Nina Caillet, Nouritza Torossian et al. · Oncotarget · 2018 · 24 citations · Full text

, , +16

Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death

Avédis Torossian, Nicolas Broin, Julie Frentzel et al. · Haematologica · 2019 · 21 citations · Full text

, , +17

Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell Lymphoma

Camille Daugrois, Chloé Bessière, Sébastien Dejean et al. · Cancers · 2021 · 12 citations · Full text

, , +17

1–5 of 5